Description
The blend of trifluridine and tipiracil is employed in the treatment of colon or rectal cancer that has metastasized to other areas of the body, especially in individuals previously treated with other chemotherapy drugs or unable to tolerate them. Trifluridine belongs to the thymidine-based nucleoside analogs class and halts the proliferation of cancer cells. Tipiracil, a thymidine phosphorylase inhibitor, prolongs the effectiveness of trifluridine by slowing its breakdown in the body.
Reviews
There are no reviews yet.